StocksMedium•1 October 2026•
1 min read
Medtronic Receives CPT Code Approvals for Hypertension and Incontinence Tech
Key Facts
1The American Medical Association approved new Category I CPT codes for Medtronic's Altaviva and Symplicity Spyral systems.
2The new codes will become effective in January 2028, replacing existing Category III codes.
The American Medical Association approved new Category I CPT codes for Medtronic's Altaviva and Symplicity Spyral systems. PR Newswire reported that these new codes will become effective in January 2028, replacing the existing Category III codes. This regulatory milestone is expected to facilitate broader physician adoption and standardized reimbursement for the company's hypertension and incontinence technologies.
MDT closed at $86.29 on September 30, 2026, after reaching a day high of $87.42. The transition to permanent Category I codes reflects growing clinical evidence and serves as a critical step for long-term commercial scaling, although the 2028 effective date delays immediate financial impact on the company's revenue.